Hyperspectral Retinal Imaging

As treatment opportunities in ophthalmology continue to advance, the need for innovative and precise diagnostic tools becomes increasingly important. Hyperspectral imaging in ophthalmology offers significant advantages in diagnosing, monitoring, and researching eye diseases. Its ability to provide detailed, non-invasive, and quantitative information makes it a valuable tool in modern ophthalmic practice. The goal of this webinar, hosted by the Vision Technical Group, is to highlight how this cutting-edge technology can transform disease diagnosis and management, leading to improved patient care and treatment outcomes.

Subject Matter Level: Introductory - Assumes little previous knowledge of the topic

What You Will Learn:
• What hyperspectral imaging is
• What advantages it presents when applied to the retina

Who Should Attend:
• Anyone interested in retinal imaging
• Vision scientists, engineers and clinicians who wish to learn about the technique and applications
 

About the Presenters:
 

Xavier Hadoux from The Center for Eye Research Australia

Dr. Xavier Hadoux is Senior Postdoctoral research fellow at the Centre for eye Research Australia (CERA) and the co-founder and Chief Technical Officer (CTO) at Enlighten Imaging Pty Ltd. Since 2015, he has applied his engineering, physics and data science knowledge to medical device development and the detection of novel biomarker for eye and brain diseases.

James Beach from The University of Minnesota

Dr. James Beach is a biomedical engineer with experience in academia and industry. His main research area is the development of new methodologies for bio-imaging and medical applications. Currently, he is also the Director for Technology Development at CytoViva, Inc, a producer of scientific and hyperspectral imaging systems located in Auburn, Alabama.